Aventis Opposes Plaintiffs' Motion for Interlocutory Appeal

BATON ROUGE, La. - The manufacturer of Arava filed an opposition to the plaintiffs' motion for certification of an interlocutory appeal of a judge's order denying their motion to remand, contending that the plaintiffs' failure to warn claim against the pharmacists who dispensed the drug is not recognized under Louisiana law. Carol Guidry, et al. v. Aventis Pharmaceuticals, et al. No. 03-493 (M.D. La.).

Aventis Pharmaceuticals contended in its motion that under U.S.C. § 1292(b), certification of an interlocutory appeal requires a controlling question of law, substantial ground for difference of opinion, and a question whose immediate appeal may materially …